Yew Bio-Pharm Group, Inc.
YEWB · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $7,486 | $9,823 | $6,075 | $5,687 |
| - Cash | $28 | $167 | $127 | $564 |
| + Debt | $9,255 | $9,604 | $9,486 | $9,338 |
| Enterprise Value | $16,712 | $19,260 | $15,433 | $14,461 |
| Revenue | $110 | $14,844 | $8,737 | $5,361 |
| % Growth | -99.3% | 69.9% | 63% | – |
| Gross Profit | -$840 | -$228 | $957 | $274 |
| % Margin | -763% | -1.5% | 11% | 5.1% |
| EBITDA | -$338 | $303 | $2,967 | $792 |
| % Margin | -306.6% | 2% | 34% | 14.8% |
| Net Income | -$1,728 | -$548 | $2,918 | -$420 |
| % Margin | -1,569% | -3.7% | 33.4% | -7.8% |
| EPS Diluted | -0.033 | -0.011 | 0.06 | -0.008 |
| % Growth | -215.1% | -117.7% | 840.7% | – |
| Operating Cash Flow | $5,895 | $1,813 | -$776 | $5,129 |
| Capital Expenditures | -$11,084 | -$4 | -$1,711 | -$6,269 |
| Free Cash Flow | -$5,189 | $1,809 | -$2,487 | -$1,139 |